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OBJECTIVES The objective of this prospective study was to determine the differences in the prognostic
significance of an exercise test (ET) that indicates a low risk of events (low-risk exercise test
[LRET]) between patients with unstable angina (UA) and those with chronic stable angina
(CSA).
BACKGROUND It is not known whether the prognostic significance of an LRET is influenced by the disease
that is the reason for performing exercise testing.
METHODS All patients not presenting with high-risk criteria were submitted to a prognostic ET. The
ET was performed by patients with CSA and patients with primary UA stabilized with
medical therapy. Medical therapy was planned for all patients. A combined end point was
defined as cardiac death, nonfatal acute myocardial infarction or hospital admission for UA.
Multivariate analysis was performed to determine the independent predictors of events.
RESULTS Low-risk criteria were fulfilled by 105 patients with UA and 86 patients with CSA. The mean
follow-up time was 347  229 days. The event rate was higher in the UA group than in the
CSA group (28% vs. 9%, p 0.001). The CSA group showed worse ET results. Performance
of ET by patients with UA was the principal predictor of events (odds ratio 4.2, p 0.0005).
CONCLUSIONS Among patients who underwent an LRET, those with UA had a rate of events significantly
higher than that of patients with CSA, despite the worse results of ET in patients with
CSA. (J Am Coll Cardiol 2001;38:1974–9) © 2001 by the American College of Cardiology
One of the most important phases in attending to patients
with coronary artery disease is risk stratification, as an
appropriate management strategy will be derived from this.
In patients with chronic stable angina (CSA), the exercise
test (ET) is the noninvasive technique most frequently used
for risk evaluation. In this group of patients, various
prognostic markers of ET have been identified (e.g., occur-
rence of angina, degree of ST-segment depression, number
of leads with ST-segment depression) (1–7), and prognostic
indexes have been compiled for some of these (2,3).
In contrast, in patients with unstable angina (UA), the
clinical and electrocardiographic (ECG) findings are deter-
minants of risk stratification and the choice of the most
appropriate therapy (8). High-risk patients (e.g., ST-
segment depression, heart failure) with UA must undergo
cardiac catheterization and revascularization therapy. Pa-
tients with low- or moderate-risk UA stabilized by medical
therapy undergo a prognostic evaluation based on an
ischemia-provoking test, usually ET, whose interpretation is
based on criteria validated in the overall population of
patients with stable coronary artery disease. However, in the
light of our experience, an ET that indicates a low risk of
events (low-risk exercise test [LRET]) does not necessarily
imply a favorable prognosis (9). This is probably because
after an acute coronary syndrome, the instability of the
atherosclerotic lesion can persist despite clinical stabilization
(10).
With these observations in mind, the objective of the
present study was to determine, by means of a prospective
study, the possible differences in the prognostic significance
of an LRET between patients with UA and those with
CSA.
METHODS
Study group. For the purposes of this prospective study,
between January 1997 and March 1999, all patients who
presented with CSA or primary UA stabilized with medical
therapy and who did not present with high-risk criteria
underwent a prognostic ET. We considered high-risk cri-
teria to be any of the following: angina with pulmonary
edema, angina with new or worsening mitral regurgitation
murmurs, angina with S3 or rales, angina with hypotension
or refractory angina. In accordance with the study protocol,
the medical therapy employed was that considered appro-
priate by the physician responsible for each individual
patient. Coronary arteriography was not performed.
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Excluded from the study were patients with rest ECG
baseline anomalies associated with an ECG response unin-
terpretable for ischemia (left bundle branch block, electron-
ically paced ventricular rhythm, pre-excitation syndrome,
ST-segment depression greater than or equal to 1 mm or
less if associated with digoxin therapy and with other criteria
of left ventricular hypertrophy) (11). Also excluded were
patients unable to complete stage II of the Bruce protocol in
the absence of inducible ischemia, as well as patients with
severe systolic dysfunction on the echocardiogram.
Definitions. Chronic angina was classified as stable when
its characteristics (e.g., frequency, severity, duration, time of
appearance, precipitating factors) had remained unchanged
over the previous three months. None of the patients with
CSA was an in-patient when ET was performed.
Unstable angina was classified in accordance with the
Braunwald (12) criteria: angina of recent appearance or
progressive angina, subacute angina at rest and acute angina
at rest. Only patients with primary UA were included.
Patients with non–Q-wave acute myocardial infarction (el-
evation of the creatine kinase level above twice the upper
limit of normal) were excluded.
Exercise test. The exercise test was performed on a tread-
mill, according to the standard Bruce protocol (13), using a
commercially available, computerized system for exercise
electrocardiography. The prescribed pharmacologic therapy
was maintained in all patients. Blood pressure was measured
before starting the test and then at 2-min intervals, at the
time of maximal effort and whenever clinically indicated.
Twelve-lead electrocardiography was performed before
starting the test and was repeated at 3-min intervals during
exercise (at the end of each stage of the Bruce protocol), at
the time of maximal effort, at 1-min intervals during at least
the first 5 min of the recovery phase and whenever consid-
ered to be clinically indicated. Throughout the test, three
ECG leads and the lead with the greatest deviation of the
ST segment were monitored continuously.
Criteria for ending the test were: 1) physical exhaustion
or achievement of the maximal heart rate permitted accord-
ing to age (220  age in years); 2) a decrease in systolic
blood pressure below the baseline or hypertensive response
(systolic blood pressure 230 mm Hg or diastolic blood
pressure 130 mm Hg); 3) ataxia, syncope or presyncope;
intense dyspnea; severe claudication; or evidence of periph-
eral hypoperfusion (cyanosis or pallor); 4) ventricular ar-
rhythmia (frequent premature ventricular contractions,
polymorphic premature ventricular contractions or three-
beat runs); 5) technical difficulties in the monitoring of
ECG or blood pressure; 6) severe angina pectoris; 7)
ST-segment depression 3 mm; and 8) a patient’s request
to terminate participation.
Criteria of a positive test were: 1) the presence of angina
(positive clinical proof); and 2) ST-segment depression 1
mm or ST-segment elevation 1 mm in the pathologic
non–Q-wave leads (not lead aVR), measured at 80 ms from
the J point (positive ECG proof). The reading of ST-
segment deviation effected by the computerized system of
exercise electrocardiography was confirmed by a cardiologist
experienced in the technique.
The Duke index was calculated from this formula: dura-
tion of exercise in minutes  (5  maximal net deviation of
the ST segment [in mm] during or after exercise)  (4 
angina index). The angina index was rated 0 if the patient
did not experience angina during the test; 1 if the patient
had angina, but this did not curtail his or her exercise; and
2 if angina was the reason for stopping the test (2).
The following were classified as high-risk criteria in the
ET: 1) a positive clinical and/or ECG response at any time,
with a heart rate 120 beats/min, or when the response
occurred during the first two stages of the Bruce protocol; 2)
ST-segment depression 1 mm, persisting 6 min in the
recovery phase or present in five or more leads; 3) ST-
segment depression 2 mm at any level of exercise; 4)
ST-segment elevation (not in lead aVR) in the non–Q-wave
leads; 5) a sustained decrease in systolic blood pressure
during progressive exercise; 6) the presence of ventricular
tachycardia; and 7) Duke index 10.
Patient management. All patients admitted to the hospital
with the diagnosis of primary UA routinely underwent
12-lead electrocardiography and determination of cardiac
enzymes (plasma CK and CK-MB isoenzyme). Exercise
testing was performed in the hospital in all patients with
UA, after 72 h of being symptom-free.
Patients with CSA underwent determination of hemo-
globin, glucose, triglycerides and total cholesterol and its
fractions. Rest electrocardiography and chest radiography
were performed in patients with signs or symptoms of heart
failure. Echocardiography was carried out in patients with a
previous myocardial infarction, pathologic Q waves on the
ECG, signs or symptoms of heart failure or a murmur
suggestive of mitral regurgitation.
An appropriate management strategy was decided pro-
spectively: patients with an ET that indicated a high risk of
events (presence of one or more of the high-risk criteria)
underwent coronary arteriography and evaluation of revas-
cularization; and patients who completed an LRET (ab-
sence of high-risk criteria) were treated medically.
Follow-up. Patients who underwent an LRET were eval-
uated in the hospital’s Cardiology Unit as outpatients at
three months after ET and subsequently every six months.
For patients who failed to attend appointments, follow-up
was achieved by means of a telephone interview conducted
Abbreviations and Acronyms
CSA  chronic stable angina
ECG  electrocardiogram or electrocardiographic
ET  exercise test(ing)
LRET  low-risk exercise test
UA  unstable angina
1975JACC Vol. 38, No. 7, 2001 Florenciano-Sa´nchez et al.
December 2001:1974–9 Low-Risk Exercise Test and Resulting Prognosis
by medical personnel. In the follow-up, events were con-
sidered in descending order of seriousness: death of cardiac
origin, nonfatal acute myocardial infarction and hospital
admission for UA. Cardiac death was considered as death
occurring in the absence of a clinical or pathologic diagnosis
of an extracardiac cause. The presence of acute myocardial
infarction or UA was confirmed in all patients by means of
the corresponding hospital clinical reports. For patients with
more than one event, only the most important was consid-
ered.
Study variables. The following variables were recorded
prospectively: 1) clinical variables: age, gender, tobacco
habit, arterial hypertension, hypercholesterolemia, diabetes
mellitus, history of ischemic heart disease (hospital admis-
sion for UA or acute myocardial infarction), previous
revascularization (coronary angioplasty and/or coronary ar-
tery bypass graft surgery), previous peripheral arterial disease
(stroke or intermittent claudication) and motive for exercise
testing (UA or CSA); 2) ECG variables: abnormal baseline
ECG; and 3) ergometric variables: duration of ET (in
minutes), maximal rate–pressure product (systolic blood
pressure  heart rate), percentage achieved of predicted
maximal heart rate, positive clinical response, positive ECG
response, positive ET result (positive clinical and/or ECG
response) and Duke index.
Statistical analysis. Quantitative variables are expressed as
the mean value  SD. Univariate comparisons between
groups of continuous variables were performed by using the
Student t test for unrelated samples, and the Mann-
Whitney U test if the data were not distributed in a normal
fashion. Qualitative variables are expressed as percentages,
and univariate comparisons were performed by using the
chi-square test and applying the Fisher correction when
necessary. Kaplan-Meier life-table curves were used to
illustrate the event-free time elapsed, using the log-rank test
for comparisons. Cox regression was used for the multivar-
iate analysis of event-free survival. We tested, in the Cox
model, the candidate predictors, including those variables
associated with the end points in the univariate analysis and
those not associated with the end points in the univariate
analysis, but with prognostic value in previous studies.
These variables were age, gender, tobacco habit, arterial
hypertension, diabetes mellitus, history of ischemic heart
disease, previous revascularization, previous peripheral arte-
rial disease, motive for exercise testing (UA or CSA),
abnormal baseline ECG, duration of ET, positive clinical
response, positive ECG response, positive ET result and
Duke index. Variables were selected in a stepwise backward
selection manner, with retention set at a significance level of
0.05. The results of these analyses are summarized as odds
ratios with corresponding 95% confidence intervals. A p
value 0.05 was considered statistically significant. All
calculations were performed using the SPSS statistical
software package.
RESULTS
During the study period, ET was performed in 206 patients
with a diagnosis of primary UA that had been stabilized
with medical therapy. Eleven patients (5%) were unable to
complete stage II of the Bruce protocol and were conse-
quently excluded from the study. Of the remaining 195
patients who underwent ET, in 87 (45%) it proved to be
high risk and in 108 (55%) low risk. Three of the 108
patients (2%) with an LRET were lost to follow-up, and the
size of this subgroup was 105.
The ET was performed by 148 patients with CSA. In 12
patients (8%), the ET was inconclusive because of their
inability to complete stage II of the Bruce protocol without
the onset of ischemia. Of the remaining 136 patients, the
ET indicated low risk in 86 (63%). None of the patients
with CSA was lost to follow-up.
Clinical characteristics. The baseline clinical characteris-
tics are shown in Table 1. The patients with UA were more
likely to be smokers and their baseline ECG was more likely
to be abnormal. There were no statistically significant
differences in the remaining clinical variables analyzed. In
patients who had undergone revascularization, this proce-
dure had taken place more than six months before their
inclusion in the study.
The majority of patients in the CSA group (80%) were in
functional class I or II of the Canadian Cardiovascular
Society. Echocardiography was performed in 89 (85%) of
the 105 patients with UA, and in 45 (52%) of the 86
patients with CSA. In the latter group, the presence of
slight or moderate left ventricular dysfunction was seen
more frequently (24% vs. 11%, p  0.1), but the difference
was not statistically significant. None of the patients in
either group had severe systolic dysfunction.
Patients with UA received more nitrates (61% vs. 38%,
p  0.0001) and cholesterol-lowering drugs (39% vs. 16%,
p  0.0001), as compared with patients with CSA. There
were no differences between patients with UA and patients
with CSA with regard to therapy with beta-blockers (32%
vs. 44%, p  NS), calcium antagonists (34% vs. 42%, p 
Table 1. Clinical Characteristics of Patients
Patients
With UA
(n  105)
Patients
With CSA
(n  86)
p
Value
Male gender 88 (84%) 66 (77%) NS
Age (yrs) 60  9 61  9 NS
Smoking 54 (51%) 22 (26%) 0.0002
Hypercholesterolemia 56 (53%) 54 (63%) NS
Hypertension 43 (41%) 42 (49%) NS
Diabetes 22 (21%) 28 (33%) 0.06
History of CAD 31 (29%) 35 (41%) NS
Previous revascularization 9 (9%) 10 (12%) NS
PVD 7 (7%) 10 (12%) NS
Abnormal baseline ECG 44 (42%) 17 (20%) 0.001
Data are presented as the number (%) of patients or mean value  SD.
CAD  coronary artery disease; CSA  chronic stable angina; ECG 
electrocardiogram; NS  not significant; PVD  peripheral vascular disease; UA 
unstable angina.
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NS), angiotensin-converting enzyme inhibitors (5% vs. 3%,
p  NS) and antiplatelet agents (75% vs. 78%, p  NS).
Exercise test results. The exercise test results are shown in
Table 2. The variables measured showed less favorable
results in the group of patients with CSA. In this group,
both the duration of the test and the Duke index were
lower, whereas the proportion of positive tests was higher.
The median interval from hospital admission to ET in
patients with UA was four days.
Events during follow-up. The mean duration of follow-up
was 347  229 days (range 30 to 960). Events occurred in
37 patients (19%). The rate of events was higher in the
group with UA (28% vs. 9%, p  0.001). The distribution
of events in the two groups is shown in Table 3.
Predictors of events. Table 4 lists the clinical, ECG and
ergometric variables that were independent predictors of
events during follow-up. The ET performed by patients
with UA was the principal predictor of events (odds ratio
[OR] 4.2, 95% confidence interval [CI] 1.8 to 9.6; p 
0.0005). Figure 1 shows the event-free survival curves for
patients with and without UA. Diabetes mellitus, previous
peripheral vascular disease and arterial hypertension were
also predictors of events. None of the variables derived from
the ET had independent predictive power. However, in the
separate analysis of the group of patients with UA, the
presence of a positive clinical response during ET was the
only independent predictor of events (OR 2.9, 95% CI 1.3
to 6.4; p  0.008).
DISCUSSION
Exercise test and prognosis. Studies on the prognostic
value of ET have been carried out in a wide range of
patients: those with UA (14–17), acute myocardial infarc-
tion (18,19) and coronary artery disease known or suspected
before coronary arteriography (2). The proportion of
LRETs in these patients varied depending on the patho-
logic findings and criteria employed to define an ET (i.e.,
high or low risk). An LRET was performed in 34% (1,2) to
77% (3) of patients with CSA or suspected coronary disease,
whereas 63% of the patients included in this study had an
LRET, probably because we included patients who, in other
studies, were classified as medium risk. The percentage of
LRETs is not well established, and in one study, almost
30% of patients with UA presented with signs of ischemia
during ET (20). Using our criteria, 55% of our patients with
UA had an LRET. Regarding baseline characteristics, the
tobacco habit and presence of an abnormal ECG were more
frequent in patients with UA, but we do not believe that
these differences influenced the results.
It has yet to be established whether the indications of ET
performed by patients with UA or CSA have any influence
on the prognostic value of an LRET. In the present study,
we found that the principal independent predictor of events
was the performance of ET by patients with UA. This
finding is concordant with the fact that, at least in patients
with UA stabilized with medical therapy, an LRET does
not necessarily indicate a good prognosis. Although the
mortality and nonfatal infarction rates in this group of
patients is low (17,21–23), hospital re-admission for UA
can reach 29% (22). Our results are in contrast to the low
rate of events associated with an LRET in the overall
Table 4. Independent Predictors of Events During Follow-Up
Reason for
Exercise Test Coefficient OR 95% CI p Value
UA 1.4 4.2 1.8–9.6 0.0005
PVD 0.8 2.4 1.0–5.9 0.04
Diabetes 0.9 2.4 1.2–4.9 0.01
Hypertension 0.7 0.4 0.2–0.9 0.04
CI  confidence interval; OR  odds ratio; other abbreviations as in Table 1.
Figure 1. Event-free survival curve (in days), according to the reason for
exercise test (i.e., chronic stable angina or unstable angina). Ch. chronic.
Table 2. Results of the Exercise Test
Patients
With UA
(n  105)
Patients
With CSA
(n  86)
p
Value
Duration (min) 9  2 7  4 0.0001
%TMHR 80  13 77  11 NS
Rate-pressure product 21,481  7,079 20,902  5,835 NS
Positive clinical response 17 (16%) 40 (46%) 0.0001
Positive ECG response 34 (32%) 57 (66%) 0.0001
Positive result 41 (39%) 64 (74%) 0.0001
Duke index 5  5 0  6 0.0001
Data are presented as the mean value  SD or number (%) of patients.
TMHR  theoretical maximal heart rate; other abbreviations as in Table 1.
Table 3. Incidence of Events
Patients
With UA
(n  105)
Patients
With CSA
(n  86) p Value
Death 2 (2%) 2 (2%) NS
Nonfatal AMI 7 (7%) 1 (1%) 0.05
Admission for UA 19 (18%) 6 (7%) 0.006
Total 28 (27%) 9 (10%) 0.001
Data are presented as the number (%) of patients.
AMI  acute myocardial infarction; other abbreviations as in Table 1.
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population of patients who undergo coronary arteriography
(2,3). In the present study, although patients with an LRET
had a low mortality rate, the group of patients with UA had
a statistically significant higher incidence of nonfatal myo-
cardial infarction (7% vs. 1%) and re-admission for UA
(19% vs. 6%). This suggests that an LRET does not carry
the same prognostic value when performed by a patient with
UA as it does when performed by a patient with CSA. This
worse prognostic significance of an LRET in our patients
with UA is clear, despite the fact that patients with CSA
had worse variables on the ET (Table 2). It is probable that
the very pathophysiology of UA—derived from the rupture
of atheromatous plaques incapable of provoking ischemia
(24)—may account for the fact that our patients had a lower
presence of flow-limiting lesions. This may explain the
relatively low predictive power of ET in this group of
patients. It is possible that coronary spasm, the spontaneous
lysis of a coronary thrombus with or without distal embo-
lisms, large plaques within the arterial wall and abnormal-
ities of the microvascular circulation may play a considerable
role in the “unstabilization” of our patients. Moreover, the
survival curves show a continuous divergence, even at the
end of the study period, at a time when one might expect a
degree of stability to result from the therapy applied in
patients with UA. It is probable that one episode of UA
identifies a patient who will have plaques that are more
vulnerable over long periods. In this respect, it would be
useful to find out whether other tests to induce ischemia,
such as stress echocardiography or scintigraphic techniques,
could provide additional prognostic information (25,26). It
would be interesting to determine whether imaging tech-
niques could also alter the specificity in the group of patients
with CSA.
In our study group, both diabetes and previous peripheral
vascular disease were associated independently with a worse
prognosis. These and other variables (previous myocardial
infarction, male gender) have been described elsewhere
(14,22) as predictors of cardiac events in patients with UA
and an LRET. Despite the fact that the univariate analysis
showed statistically significant differences between the
groups with regard to the tobacco habit variable, the
multivariate analysis did not find this to be an independent
predictor of events. A possible explanation might be that
patients with UA stop smoking after their first hospital
admission. The present study suggests that certain other
clinical variables should be taken into account when deter-
mining the prognosis of a patient with an LRET, especially
the diagnosis of the patient before ET is performed. In
addition, given that an LRET in patients with UA does not
indicate a good prognosis, future studies should attempt to
determine whether an aggressive management strategy
might be indicated in this group of patients.
Study limitations. Our study group consisted of a highly
selected group of patients: individuals at high risk because of
clinical or ergometric variables were excluded from the
study. Consequently, our results are not applicable to the
overall population of patients with UA or CSA.
Hospital re-admission for UA may be problematic as an
end point. Perhaps patients with UA manifest their symp-
toms more clearly than patients with CSA, or they are more
frequently integrated into medical systems, with the result
that such patients may be more easily re-admitted. How-
ever, hospital re-admission for UA is an end point accepted
in several prognostic studies of patients with UA (4,20).
Conclusions. The result of ET carried out for a prognostic
purpose is usually worse in patients with CSA than in those
with UA stabilized with medical therapy. However, in
patients with an LRET, those with UA have a significantly
higher incidence of recurrent ischemic events than that of
patients with CSA. This allows the deduction that the
prognostic significance of ET is dissimilar between the two
patient groups.
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